UBS Group’s VSEE HEALTH INC WTS 29 VSEEW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56 Sell
1,586
-915
-37% -$52 ﹤0.01% 10193
2025
Q4
$195 Buy
2,501
+1,899
+315% +$202 ﹤0.01% 10117
2025
Q3
$10 Sell
602
-1,885
-76% -$72 ﹤0.01% 10193
2025
Q2
$87 Hold
2,487
﹤0.01% 10015
2025
Q1
$147 Sell
2,487
-525
-17% -$26 ﹤0.01% 9919
2024
Q4
$151 Sell
3,012
-2,446
-45% -$130 ﹤0.01% 9600
2024
Q3
$218 Sell
5,458
-942
-15% -$102 ﹤0.01% 9057
2024
Q2
$1.38K Buy
+6,400
New +$964 ﹤0.01% 8583
2023
Q4
Sell
-145
Closed -$3 9991
2023
Q3
$3 Sell
145
-135
-48% -$4 ﹤0.01% 9329
2023
Q2
$18 Buy
+280
New +$23 ﹤0.01% 8697
2023
Q1
Sell
-4,710
Closed -$471 10533
2022
Q4
$471 Sell
4,710
-4,920
-51% -$519 ﹤0.01% 10170
2022
Q3
$1K Hold
9,630
﹤0.01% 10062
2022
Q2
$1K Buy
+9,630
New +$1.38K ﹤0.01% 9992

Other funds holding VSEEW

UBS Group's VSEEW Position: Q1 2026 in Review

UBS Group reduced its VSEE HEALTH INC WTS 29 (VSEEW) stake by 37% in Q1 2026, selling an estimated $52 and leaving 1,586 shares worth $56. The position accounts for ﹤0.01% of the portfolio, ranked #10193.

UBS Group first reported a position in VSEEW in Q2 2022 and has held it in 13 quarters since. The position peaked at $1.38K in Q2 2024. 19 funds tracked by Wall St. Rank hold VSEEW as of Q1 2026.

  • UBS Group held 1,586 shares of VSEE HEALTH INC WTS 29 worth $56 as of Q1 2026.
  • UBS Group sold 915 VSEE HEALTH INC WTS 29 shares in Q1 2026, an estimated $52.
  • VSEE HEALTH INC WTS 29 made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #10193 holding.
  • UBS Group first reported a position in VSEE HEALTH INC WTS 29 in Q2 2022 and has held it in 13 quarters since.
  • UBS Group's VSEE HEALTH INC WTS 29 position peaked at $1.38K in Q2 2024.
  • 19 funds tracked by Wall St. Rank held VSEE HEALTH INC WTS 29 as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.